Genitourinary Cancer: Chaired by Earle F. Burgess, MD

Partner | Cancer Centers | <b>Atrium Health Levine Cancer Institute</b>

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of genitourinary cancer.

Genitourinary Cancer: Chaired by Earle F. Burgess, MD

The live filming of this virtual event in our IPC series is now on-demand.

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of oncology.

Speakers:

  • Earle F. Burgess, MD | Levine Cancer Institute Medical Oncology
  • Jason Zhu, MD | Levine Cancer Institute Medical Oncology
  • Claud M. Grigg Jr., MD | Levine Cancer Institute Medical Oncology
  • Justin Matulay, MD | Levine Cancer Institute

Topics:

  • Updates in First-Line Treatment Options for Metastatic Urothelial Cancer
  • Treatment for Previously Treated, Locally Advanced or Metastatic Urothelial Cancer
  • Newly Diagnosed mRCC
  • Update on the Role for Cytoreductive Nephrectomy